Kiora Pharmaceuticals (KPRX) Current Deferred Revenue (2015 - 2019)
Kiora Pharmaceuticals' (KPRX) quarterly Current Deferred Revenue came in at -$2.7 million in Q4 2019, down 200.0% YoY from $2.7 million in Q4 2018, and down 200.0% on a QoQ basis from $2.7 million in Q4 2018.
Kiora Pharmaceuticals (KPRX) Current Deferred Revenue (2015 - 2019) Analysis & Trends
Kiora Pharmaceuticals (KPRX) has 5 years of Current Deferred Revenue data on file, last reported at -$2.7 million in Q4 2019.
- Quarterly Current Deferred Revenue fell 200.0% year-over-year to -$2.7 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was -$2.7 million (down 200.0% YoY) and the FY2019 annual result came in at -$2.7 million, down 200.0% from the prior year.
- Current Deferred Revenue retreated to -$2.7 million in Q4 2019, from $2.7 million in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $12.3 million in Q4 2017 to a low of -$2.7 million in Q4 2019.
- A 5-year average of $4.2 million and a median of $2.7 million in 2018 frame the typical range for Current Deferred Revenue.
- Annual changes were most pronounced in 2017 — Current Deferred Revenue surged 245.7% — and 2019, when it sank 200.0%.
- Tracing KPRX's Current Deferred Revenue over 5 years: stood at $1.9 million in 2015, then surged by 121.49% to $4.2 million in 2016, then surged by 191.45% to $12.3 million in 2017, then sank by 78.19% to $2.7 million in 2018, then slumped by 200.0% to -$2.7 million in 2019.
- The last three Current Deferred Revenue figures came in at -$2.7 million (Q4 2019), $2.7 million (Q4 2018), and $2.7 million (Q3 2018), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Kiora Pharmaceuticals | 16.25 Mn | 16.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -2.69 Mn |
| Dec 31, 2018 | 2.69 Mn |
| Sep 30, 2018 | 2.69 Mn |
| Jun 30, 2018 | 2.72 Mn |
| Mar 31, 2018 | 2.86 Mn |
| Dec 31, 2017 | 12.31 Mn |
| Sep 30, 2017 | 10.25 Mn |
| Jun 30, 2017 | 8.86 Mn |
| Mar 31, 2017 | 8.23 Mn |
| Dec 31, 2016 | 4.23 Mn |
| Sep 30, 2016 | 3.42 Mn |
| Jun 30, 2016 | 2.56 Mn |
| Mar 31, 2016 | 2.66 Mn |
| Dec 31, 2015 | 1.91 Mn |
| Sep 30, 2015 | 1.00 Mn |